Inventor · disambiguated record
Thomas Dull
Also filed as: DULL THOMAS · DULL THOMAS J
21 granted patents·1 pending application·2,117 citations·filing 1986–2007
97Inventor score
Top patents by PatentIndex Score
22 records- 0198US6428953B1Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2000·Granted Aug 6, 2002·125 cites·9 claims
- 0298US5994136AMethod and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 1997·Granted Nov 30, 1999·743 cites·16 claims
- 0397US4859609ANovel receptors for efficient determination of ligands and their antagonists or agonistsGENENTECH INC·Filed 1986·Granted Aug 22, 1989·236 cites·15 claims
- 0496US7179903B2Liver specific transcriptional enhancerCELL GENESYS INC·Filed 2004·Granted Feb 20, 2007·89 cites·9 claims
- 0596US7083981B2Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2005·Granted Aug 1, 2006·26 cites·14 claims
- 0696US6165782AMethod and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 1999·Granted Dec 26, 2000·182 cites·9 claims
- 0795US8846385B2Method and means for producing high titer, safe recombinant lentivirus vectorsNALDINI LUIGI·Filed 2006·Granted Sep 30, 2014·31 cites·18 claims
- 0895US6808905B2Lentiviral vectors encoding clotting factors for gene therapyCELL GENESYS INC·Filed 2002·Granted Oct 26, 2004·64 cites·33 claims
- 0995US5686279AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1994·Granted Nov 11, 1997·151 cites·18 claims
- 1093US7745179B2Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using sameGBP IP LLC·Filed 2007·Granted Jun 29, 2010·53 cites·28 claims
- 1193US5858740AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1995·Granted Jan 12, 1999·91 cites·50 claims
- 1292US6506604B2Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 2001·Granted Jan 14, 2003·32 cites·22 claims
- 1392US5834256AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1993·Granted Nov 10, 1998·104 cites·99 claims
- 1491US7250299B1Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2000·Granted Jul 31, 2007·31 cites·18 claims
- 1590US5030576AReceptors for efficient determination of ligands and their antagonists or agonistsGENENTECH INC·Filed 1989·Granted Jul 9, 1991·84 cites·7 claims
- 1686US7252991B2Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 2002·Granted Aug 7, 2007·11 cites·1 claims
- 1786US6924144B2Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2002·Granted Aug 2, 2005·8 cites·17 claims
- 1882US8652837B2Method and means for producing high titer, safe, recombinant lentivirus vectorsNALDINI LUIGI·Filed 2007·Granted Feb 18, 2014·4 cites·21 claims
- 1980US6218187B1Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1999·Granted Apr 17, 2001·42 cites·51 claims
- 2055US6797505B2Recombinant AAV vectors for gene therapy of hemophilia ACELL GENESYS INC·Filed 1998·Granted Sep 28, 2004·10 cites·20 claims
- 2149US2004092008A1Recombinant AAV vectors for gene therapy of hemophilia AFiled 2002·Application pending·0 cites
- 2230US5756333ARecombinant production of lactoperoxidaseINCYTE PHARMA INC·Filed 1994·Granted May 26, 1998·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →